Assessment of IMPACT III Emotional and Social Functioning Domain Scores in Adalimumab-Treated Pediatric Patients With Crohn's Disease

被引：0
|
作者：
Grant, Amy
Otley, Anthony R.
Escher, Johanna
Hyams, Jeffrey S.
Maa, Jen-Fue
Alperovich, Gabriela
Lazar, Andreas
Robinson, Anne M.
Wang, Anthony
Eichner, Samantha
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)33397-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu2005
引用
收藏
页码：S1003 / S1004
页数：2
相关论文
共 50 条
  • [1] Assessment of IMPACT III emotional and social functioning domain scores in adalimumab-treated paediatric patients with Crohn's disease
    Grant, A.
    Otley, A.
    Escher, J.
    Hyams, J. S.
    Maa, J. -F.
    Alperovich, G.
    Lazar, A.
    Robinson, A. M.
    Wang, A. W.
    Eichner, S.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S424 - S425
  • [2] Economic Impact of Deep Remission in Adalimumab-Treated Patients With Crohn's Disease: Results From Extend
    Sandborn, William J.
    Colombel, Jean-Frederic
    Louis, Edouard
    Panaccione, Remo
    Yang, Mei
    Chao, Jingdong
    Mulani, Parvez
    GASTROENTEROLOGY, 2011, 140 (05) : S205 - S205
  • [3] Patient support program for adalimumab-treated patients with Crohn's disease in Brazil: impact on patients' adherence and persistence
    Teich, V.
    Arinelli, R.
    Gulart, A.
    Chaves, L.
    Garg, V.
    Skup, M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S306 - S307
  • [4] Subanalysis of Remission Rates By Duration of Disease in Adalimumab-Treated Patients with Crohn's Disease: the Care Trial
    Reinisch, Walter
    Lofberg, Robert
    Louis, Edouard
    Kron, Martina
    Camez, Anne
    Robinson, Anne
    Pollack, Paul F.
    GASTROENTEROLOGY, 2009, 136 (05) : A523 - A524
  • [5] IMPROVEMENT IN SHORT INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE SCORES IN ADALIMUMAB-TREATED CROHN'S DISEASE PATIENTS WHO FAILED INFLIXIMAB (CHOICE TRIAL)
    Lichtiger, S.
    Present, D. H.
    Wu, E.
    Beaulieu, N.
    Kent, J. D.
    Lomax, K. G.
    Chao, J.
    Mulani, P.
    GUT, 2009, 58 : A98 - A98
  • [6] Improvement in short inflammatory bowel disease questionnaire scores in adalimumab-treated Crohn's disease patients who failed infliximab (CHOICE trial)
    Lichtiger, Simon
    Present, Daniel H.
    Wu, Eric
    Beaulieu, Nicolas
    Kent, Jeffrey D.
    Lomax, Kathleen G.
    Chao, Jingdong
    Mulani, Parvez
    GASTROENTEROLOGY, 2008, 134 (04) : A474 - A475
  • [7] Improvements in Work Productivity and Quality of Life in Adalimumab-Treated Patients with Crohn's Disease: the Care Trial
    Louis, Edouard
    Lofberg, Robert
    Reinisch, Walter
    Chen, Naijun
    Chao, Jingdong
    Mulani, Parvez
    GASTROENTEROLOGY, 2009, 136 (05) : A179 - A179
  • [8] Crohn's Disease Mucosal Healing in Adalimumab-Treated Patients is Affected by Disease Duration: Results From Extend
    Sandborn, William J.
    Panaccione, Remo
    Thakkar, Roopal
    Lomax, Kathleen G.
    Chen, Naijun
    Chao, Jingdong
    Mulani, Parvez
    Yang, Mei
    GASTROENTEROLOGY, 2010, 138 (05) : S164 - S164
  • [9] Steroid-free remission in adalimumab-treated pediatric patients with moderately to severely active Crohn's disease in the IMAgINE 1 trial
    Crandall, W.
    Griffiths, A.
    Colletti, R.
    Ruemmele, F.
    Faubion, W. W.
    Hyams, J. S.
    Lazar, A.
    Li, Y.
    Eichner, S.
    Thakkar, R. B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 150 - 150
  • [10] Growth improvement in adalimumab-treated paediatric patients with Crohn's disease: data from IMAgINE 1
    Walters, T.
    Faubion, W. A.
    Griffiths, A.
    Baldassano, R.
    Escher, J.
    Ruemmele, F.
    Hyams, J. S.
    Lazar, A.
    Eichner, S.
    Li, Y.
    Pappalardo, B.
    Thakkar, R. B.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S420 - S421
12345